Clinical Trial Update: Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating solifenacin as add-on therapy for overactive bladder symptoms in men treated for benign prostatic hyperplasia. The study is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Overactive Bladder

Drugs mentioned

• Vesicare (solifenacin succinate)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy | Phase 4 | Status: COMPLETED